[Effect of age on the pharmacokinetic parameters of digoxin]. 1984

O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ

Digoxin pharmacokinetics was studied in 40 virtually healthy subjects aged 60-89 years and 10 subjects aged 20-29 years injected with a single dose (0.5 mg) of digoxin. The pharmacokinetic data were interpreted in terms of a two-compartmental model. The constant of digoxin transfer rate from the peripheral compartment to the central one appreciably increased, whereas the elimination constant and the magnitude of the total clearance was decreased with aging. The values of the apparent volume of the drug distribution in the central compartment, as well as those of the stationary and kinetic volumes of distribution got reduced. In elderly and senile subjects, the pharmacokinetic curve area increased. The half-life of digoxin in young, elderly and senile subjects was equal to 51, 54 and 57 h, respectively.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
January 1988, Acta poloniae pharmaceutica,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
May 2007, European journal of clinical pharmacology,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
October 1989, International journal of clinical pharmacology, therapy, and toxicology,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
July 1985, Research communications in chemical pathology and pharmacology,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
June 1979, Clinical pharmacology and therapeutics,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
February 1991, Veterinarni medicina,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
September 1983, Die Pharmazie,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
September 1978, International journal of clinical pharmacology and biopharmacy,
O V Korkushko, and P A Orlov, and I S Bezverkhaia, and A A Belyĭ
December 1974, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!